Welch & Forbes LLC Pfizer Inc Transaction History

Welch & Forbes LLC

$7.73 Billion
Q3 2024

A detailed history of Welch & Forbes LLC transactions in Pfizer Inc stock. As of the latest transaction made, Welch & Forbes LLC holds 456,190 shares of PFE stock, worth $12.5 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

456,190

Previous 465,965 2.1%

Holding current value

$12.5 Million

Previous $13 Million 1.27%

% of portfolio

0.17%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$27.7 - $31.39 $270,767 - $306,837	-9,775 Reduced 2.1%	456,190 $13.2 Million
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $142,390 - $166,855	-5,637 Reduced 1.2%	465,965 $13 Million
Q1 2024 May 02, 2024	SELL	$25.89 - $29.73 $879,276 - $1.01 Million	-33,962 Reduced 6.72%	471,602 $13.1 Million
Q4 2023 Feb 06, 2024	SELL	$26.13 - $33.94 $1.45 Million - $1.89 Million	-55,677 Reduced 9.92%	505,564 $14.6 Million
Q3 2023 Nov 02, 2023	SELL	$32.09 - $37.51 $428,754 - $501,171	-13,361 Reduced 2.33%	561,241 $18.6 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $213,433 - $246,937	-5,909 Reduced 1.02%	574,602 $21.1 Million
Q1 2023 Apr 14, 2023	SELL	$39.39 - $51.28 $142,394 - $185,377	-3,615 Reduced 0.62%	580,511 $23.7 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $185,829 - $242,579	4,451 Added 0.77%	584,126 $29.9 Million
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $174,777 - $213,359	-3,994 Reduced 0.68%	579,675 $25.4 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $472,512 - $560,251	-10,155 Reduced 1.71%	583,669 $30.6 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $2.05 Million - $2.54 Million	-44,784 Reduced 7.01%	593,824 $30.7 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $57,352 - $85,015	-1,388 Reduced 0.22%	638,608 $37.7 Million
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $101,068 - $129,831	-2,575 Reduced 0.4%	639,996 $27.5 Million
Q2 2021 Jul 22, 2021	SELL	$35.91 - $40.68 $12,101 - $13,709	-337 Reduced 0.05%	642,571 $25.2 Million
Q1 2021 Apr 14, 2021	SELL	$33.49 - $37.77 $240,860 - $271,641	-7,192 Reduced 1.11%	642,908 $23.3 Million
Q4 2020 Jan 20, 2021	SELL	$33.47 - $42.56 $4.62 Million - $5.88 Million	-138,088 Reduced 17.52%	650,100 $23.9 Million
Q3 2020 Oct 23, 2020	SELL	$31.75 - $37.25 $336,518 - $394,812	-10,599 Reduced 1.33%	788,188 $28.9 Million
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $749,988 - $909,846	-24,900 Reduced 3.02%	798,787 $26.1 Million
Q1 2020 Apr 17, 2020	SELL	$27.03 - $38.62 $1.37 Million - $1.96 Million	-50,789 Reduced 5.81%	823,687 $26.9 Million
Q4 2019 Jan 17, 2020	SELL	$32.92 - $37.36 $378,711 - $429,789	-11,504 Reduced 1.3%	874,476 $34.3 Million
Q3 2019 Oct 11, 2019	SELL	$32.49 - $42.13 $441,246 - $572,167	-13,581 Reduced 1.51%	885,980 $31.8 Million
Q2 2019 Jul 12, 2019	SELL	$36.98 - $41.52 $351,938 - $395,145	-9,517 Reduced 1.05%	899,561 $39 Million
Q1 2019 Apr 29, 2019	SELL	$37.5 - $41.2 $627,300 - $689,193	-16,728 Reduced 1.81%	909,078 $38.6 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $488,145 - $556,539	-12,689 Reduced 1.35%	925,806 $40.4 Million
Q3 2018 Oct 17, 2018	SELL	$34.47 - $41.81 $743,483 - $901,799	-21,569 Reduced 2.25%	938,495 $41.4 Million
Q2 2018 Jul 16, 2018	SELL	$32.98 - $35.16 $437,974 - $466,924	-13,280 Reduced 1.36%	960,064 $34.8 Million
Q1 2018 Apr 12, 2018	SELL	$31.91 - $37.02 $92,251 - $107,024	-2,891 Reduced 0.3%	973,344 $34.5 Million
Q4 2017 Jan 26, 2018	SELL	$33.26 - $35.29 $574,766 - $609,846	-17,281 Reduced 1.74%	976,235 $35.4 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $30.8 Million - $33.9 Million	993,516	993,516 $35.5 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch & Forbes LLC with notifications on news.

Account